A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs
Public ClinicalTrials.gov record NCT04908202. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Psoriatic Arthritis Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs
Study identification
- NCT ID
- NCT04908202
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 670 participants
Conditions and interventions
Conditions
Interventions
- Deucravacitinib Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 12, 2021
- Primary completion
- Sep 4, 2024
- Completion
- Jun 9, 2027
- Last update posted
- Apr 22, 2026
2021 – 2027
United States locations
- U.S. sites
- 33
- U.S. states
- 22
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0197 | Gilbert | Arizona | 85297 | — |
| Local Institution - 0188 | Jonesboro | Arkansas | 72401 | — |
| Local Institution - 0168 | Fontana | California | 92335 | — |
| Local Institution - 0199 | Fullerton | California | 92835 | — |
| Local Institution - 0038 | Sacramento | California | 95815 | — |
| Cohen Medical Centers | Thousand Oaks | California | 91360 | — |
| Local Institution - 0170 | Denver | Colorado | 80230 | — |
| Local Institution - 0195 | Clearwater | Florida | 33765 | — |
| Local Institution - 0272 | Margate | Florida | 33063 | — |
| Local Institution - 0082 | Miami Lakes | Florida | 33014 | — |
| Local Institution - 0171 | Gainesville | Georgia | 30501 | — |
| Local Institution - 0087 | Boise | Idaho | 83702 | — |
| Local Institution - 0080 | Chicago | Illinois | 60640 | — |
| Local Institution - 0177 | Orland Park | Illinois | 60467 | — |
| Local Institution - 0178 | Schaumburg | Illinois | 60195 | — |
| Local Institution - 0083 | Lexington | Kentucky | 40504 | — |
| Local Institution - 0042 | Hagerstown | Maryland | 21740 | — |
| Local Institution - 0198 | Detroit | Michigan | 48202 | — |
| Local Institution - 0201 | Springfield | Missouri | 65807 | — |
| Local Institution - 0268 | Kalispell | Montana | 59901 | — |
| Local Institution - 0186 | Voorhees Township | New Jersey | 08043 | — |
| University Hospitals Cleveland Medical Center-Dermatology | Cleveland | Ohio | 44106 | — |
| Local Institution - 0028 | Middleburg Heights | Ohio | 44130 | — |
| Local Institution - 0179 | Perrysburg | Ohio | 43551 | — |
| Local Institution - 0182 | Oklahoma City | Oklahoma | 73102 | — |
| Local Institution - 0185 | Corvallis | Oregon | 97330 | — |
| Local Institution - 0175 | Greenville | South Carolina | 29601 | — |
| Local Institution - 0036 | Jackson | Tennessee | 38305 | — |
| Local Institution - 0172 | Allen | Texas | 75013 | — |
| Local Institution - 0189 | Amarillo | Texas | 79124 | — |
| Local Institution - 0032 | Dallas | Texas | 75231 | — |
| Local Institution - 0273 | Bothell | Washington | 98021 | — |
| Local Institution - 0181 | Beckley | West Virginia | 25801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 150 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04908202, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 22, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04908202 live on ClinicalTrials.gov.